• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Enpro Inc. to Acquire Advanced Micro Instruments, Inc.

Share:

January 2, 2024

Enpro Inc. announced its acquisition of Advanced Micro Instruments (AMI) for $210 million. AMI, a provider of specialized analyzers, monitors critical parameters in various industries like natural gas, biogas, and aerospace. This addition to Enpro’s Sealing Technologies segment will enhance their portfolio, particularly in environmental safeguarding. The move aligns with Enpro’s strategy to invest in technologies for critical environments and is projected to boost segment growth and earnings per share.

Enpro Inc. (NYSE: NPO), an industrial technology company, today announced that it has entered into a definitive agreement to acquire Advanced Micro Instruments, Inc. (“AMI”), a leading provider of highly-engineered, application-specific analyzers and sensing technologies that monitor critical parameters to maintain infrastructure integrity, enable process efficiency, enhance safety, and facilitate the clean energy transition. Under the terms of the agreement, Enpro will acquire AMI for $210 million in cash, representing a valuation of approximately 13x normalized 2023 EBITDA.

Based in Costa Mesa, California, AMI serves customers in the midstream natural gas, biogas, industrial processing, cryogenics, food processing, laboratory, wastewater and aerospace markets. The company offers a portfolio of oxygen, hydrogen sulfide and moisture analyzers and proprietary sensing capabilities that detect contaminants in a variety of processes, including natural gas and biogas streams, which enable operators to avoid flaring and, thereby, reduce CO2 emissions.

Upon closing, AMI will be included in the Sealing Technologies segment, adding to the segment’s portfolio of products and solutions that safeguard critical environments. The acquisition is expected to be accretive to segment revenue growth and profitability, in addition to Enpro’s adjusted diluted earnings per share.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Acquiring AMI, an industry leader, will build on our strategy to invest in products and technologies that safeguard critical environments in key secular growth markets,” said Eric Vaillancourt, President and Chief Executive Officer. “AMI’s innovative analyzer and sensor solutions will add to our existing portfolio of critical process technologies in the Sealing Technologies segment, and this acquisition will be an important step forward in expanding our capabilities into compositional analysis. We look forward to welcoming the talented AMI team to the Enpro family of companies and capitalizing on our combined capabilities.”

“We look forward to joining the Enpro family and this is an exciting next chapter for AMI,” said Kevin Bates, President and Chief Executive Officer of AMI. “AMI fits squarely into Enpro’s portfolio of leading-edge solutions in a variety of growing end markets that have strong technological and applied engineering advantages. Enpro is the ideal partner for us to accelerate our future growth.”

The transaction is expected to close in early 2024, subject to limited closing conditions, including regulatory approvals.

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Skin Checking App Miiskin Launches Mole Sizing FeatureSkin Checking App Miiskin Launches Mole Sizing Feature
  • Alira Health Extends Its Global Market Access Capabilities Through the Acquisition of WellmeraAlira Health Extends Its Global Market Access Capabilities Through the Acquisition of Wellmera
  • Merck Buys Animal Health Company AntelliqMerck Buys Animal Health Company Antelliq
  • Big Pharma makes strongest start to M&A for a decadeBig Pharma makes strongest start to M&A for a decade
  • Solving Healthcare’s Data Challenges With Storage-As-A-ServiceSolving Healthcare’s Data Challenges With Storage-As-A-Service
  • IncellDx’s Chronic COVID Treatment Center Partners with ARISE MD Integrative Medicine & Surgery to Evaluate Novel Therapeutic Approach to Chronic COVIDIncellDx’s Chronic COVID Treatment Center Partners with ARISE MD Integrative Medicine & Surgery to Evaluate Novel Therapeutic Approach to Chronic COVID
  • Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed MergerLeading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
  • Levine Leichtman Capital Partners Portfolio Company Capsa Healthcare Acquires RoboPharmaLevine Leichtman Capital Partners Portfolio Company Capsa Healthcare Acquires RoboPharma

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications